AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

2024 Avoca Industry Survey

The survey is now closed — thank you for your participation!

Avoca, a WCG company, takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our survey focuses on potential changes in regulatory guidance under ICH E6 (R3). Importantly, you don’t need to be familiar with this draft guidance to participate – rather, we will provide information about anticipated changes and would like to understand your thoughts and reactions.

A report of aggregate findings and take-aways from the research is now available under Avoca’s Research Reports library.

 


 

RELATED CONTENT:

The 2023 WCG Avoca State of the Industry Report:
A 360° Assessment of the Clinical Trial Industry
Learn more and access report ››